Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterocyclic Compounds: Importance in Anticancer Drug Discovery
Naresh Kumar, Nidhi Goel
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 19, pp. 3196-3207
Closed Access | Times Cited: 23

Showing 23 citing articles:

Recent advances in the synthesis of organoselenium heterocycle conjugates
Saad Shaaban, Hussein Ba-Ghazal, Yasair S. Al-Faiyz, et al.
Tetrahedron (2024) Vol. 157, pp. 133957-133957
Closed Access | Times Cited: 10
Computational Study on Anthrapyrazoles, Anthraisoxazoles, and Proposed Anthraisothiazoles: DFT and Molecular Docking Analysis
Praful Patil, Nagaiyan Sekar
ChemistrySelect (2025) Vol. 10, Iss. 1
Open Access
Pyrazole-thiazole hybrids: Synthesis, computational studies and impact on digestive enzymes
Sidhant Yadav, Raman Lakhia, Anjaneyulu Bendi, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 138847-138847
Closed Access | Times Cited: 5
Synthesis, Characterization, and Evaluation of Tetrazole Derivatives with Pyrrole‐2,5‐Dione Moieties as Urease Inhibitors: Exploring Structure‐Activity Relationships and Computational Insights
Dara Muhammed Aziz, Sangar Ali Hassan
ChemistrySelect (2024) Vol. 9, Iss. 23
Closed Access | Times Cited: 4
Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications
Jiatong Li, Ao Gu, Xiao‐Mei Nong, et al.
The Chemical Record (2023) Vol. 23, Iss. 12
Closed Access | Times Cited: 13
New pyrimidinothiophene derivatives: Synthesis, spectroscopic analysis, X-ray, DFT calculation, biological activity studies and ADMET prediction
Yuyu Ding, Yan Zhang, Longjia Yan, et al.
Journal of Molecular Structure (2023) Vol. 1290, pp. 135952-135952
Closed Access | Times Cited: 8
Strategic One-Pot Synthesis of 1,2,3-Triazole-Based Dihydropyrimidinone Hybrids Using Magnetic CuFe2O4 NPS as Heterogeneous Catalyst and Their DFT, Molecular Docking Studies
Anjaneyulu Bendi, Chinmay Mittal, Vishaka Chauhan, et al.
Journal of Molecular and Engineering Materials (2024) Vol. 12, Iss. 01n02
Closed Access | Times Cited: 2
An Investigation of Novel Series of 2-Thioxo-1,3-dithiol-carboxamides as Potential Antispasmodic Agents: Design, Synthesis via Coupling Reactions, Density Functional Theory Calculations, and Molecular Docking
Riham Sghyar, Mouad Lahyaoui, Noura Aflak, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3855-3855
Open Access | Times Cited: 1
Novel Indole-Tethered Chromene Derivatives: Synthesis, Cytotoxic Properties, and Key Computational Insights
M. Shaheer Malik, Hissana Ather, Shaik Mohammad Asif Ansari, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 333-333
Open Access | Times Cited: 5
Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)
Rohit Pal, B. Kumaraswamy, S. K. Md. Ashadul, et al.
ChemistrySelect (2024) Vol. 9, Iss. 30
Closed Access | Times Cited: 1
Syntheses and Cytotoxicities of Quinazolinone-Based Conjugates
Hieu Trong Le, Kiep Minh, Quy Phu Nguyen, et al.
Chemical and Pharmaceutical Bulletin (2024) Vol. 72, Iss. 1, pp. 61-67
Open Access
Development of phenolic acids-based system as anticancer drugs
Luís R. Silva, S. Sofia M. Rodrigues, Naresh Kumar, et al.
Elsevier eBooks (2024), pp. 255-294
Closed Access
Multicomponent reaction strategy to heterocyclic compounds in anticancer drug design
Suman Majee, Sakshi Priya, Vaibhav Kumar, et al.
Elsevier eBooks (2024), pp. 551-595
Closed Access
Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements
Sneha Gupta, Sumeet Jha, Supriya Rani, et al.
ChemistryOpen (2024)
Open Access
Co-crystals of thiobarbituric acid and N-heterocyclic compounds: Synthesis, structural, solubility, computational, and antilymphoma activity
Nidhi Goel, Hem Lata, Dhananjay S. Raghubanshi, et al.
Next Materials (2024) Vol. 7, pp. 100375-100375
Closed Access
New 2,4-diphenylaminopyrimidinothiophene derivatives: Synthesis, Spectroscopic analysis, X-ray, DFT calculation, ADMET prediction, and Biological activity
Xiaoling He, Ting Yang, Wenqiang Zhu, et al.
Journal of Molecular Structure (2024), pp. 140170-140170
Closed Access
Promising Novel Heterocyclic Drug Candidates: Synthesis, Characterization, DFT Calculations and In Silico Investigations of Anticancer Behaviors
Ömer Dilek, Tolga A. Yeşil, Tahir Tilki
Polycyclic aromatic compounds (2024), pp. 1-21
Closed Access
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access
Dual Ce@g-C3N4-Photoredox/Chlorine Catalysis: Cross-Dehydrogenative Coupling of N-Heteroarenes and Alkanes/Ethers with H2 Evolution
Hong‐Tao Ji, Yu-Qi Tang, Yaohui Wang, et al.
Organic Letters (2024) Vol. 26, Iss. 46, pp. 9822-9827
Closed Access
Discovery of Novel Bicyclic and Tricyclic Cyclohepta[b]thiophene Derivatives as Multipotent AChE and BChE Inhibitors, In-Vivo and In-Vitro Assays, ADMET and Molecular Docking Simulation
Eman A. Fayed, Samiha A. El‐Sebaey, Maha A. Ebrahim, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117201-117201
Closed Access
Recent Updates on Morpholino Pyrimidine Derivatives as Promising PI3K/Akt/mTOR Inhibitors
Khandelwal Keertika, Swagatika Behera, Nutan Sharma
Chemistry Africa (2024)
Closed Access
Role of the Heterocycles to Design Anti-Cancer Agents
Bubun Banerjee
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 19, pp. 3194-3195
Closed Access | Times Cited: 2
Research and Development of Supramolecules as Anticancer Drugs
Manjit Manjit, Brahmeshwar Mishra
Springer eBooks (2022), pp. 55-87
Closed Access
Page 1

Scroll to top